Hidradenitis Suppurativa (HS)

Also known as: Hidradenitis Suppurativa / Verneuil's disease / Acne inversa / Hidradenitis suppurativa (disorder) / Hidradenitis / Hidradenitis (disorder) / Sweat gland inflammation

Drug	Drug Name	Drug Description
DB00051	Adalimumab	A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DB00994	Neomycin	An aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body.

Drug	Drug Name	Target	Type
DB00051	Adalimumab	Tumor necrosis factor	target
DB00994	Neomycin	30S ribosomal protein S12	target
DB00994	Neomycin	16S ribosomal RNA	target
DB00994	Neomycin	Extracellular calcium-sensing receptor	target

Drug	Drug Name	Phase	Status	Count
DB11776	Brodalumab	0	Completed	2
DB11776	Brodalumab	0	Withdrawn	1
DB17743	Fecal microbiota	0	Recruiting	1
DB11834	Guselkumab	0	Withdrawn	1
DB00065	Infliximab	0	Completed	1
DB00281	Lidocaine	0	Not Yet Recruiting	1
DB00750	Prilocaine	0	Not Yet Recruiting	1
DB09029	Secukinumab	0	Completed	1
DB06371	Siplizumab	0	Not Yet Recruiting	1
DB00051	Adalimumab	1	Completed	1
DB16359	CSL324	1	Completed	1
DB00095	Efalizumab	1	Completed	1
DB00099	Filgrastim	1	Completed	1
DB01611	Hydroxychloroquine	1 / 2	Completed	1
DB12711	LTX-109	1 / 2	Completed	1
DB00051	Adalimumab	2	Completed	4
DB00051	Adalimumab	2	Terminated	1
DB00026	Anakinra	2	Completed	2
DB05676	Apremilast	2	Completed	2
DB15011	Avacopan	2	Completed	1
DB14947	Bermekimab	2	Completed	2
DB14947	Bermekimab	2	Terminated	1
DB12917	Bimekizumab	2	Completed	1
DB11776	Brodalumab	2	Unknown Status	1
DB16650	Deucravacitinib	2	Recruiting	1
DB01395	Drospirenone	2	Terminated	1
DB00005	Etanercept	2	Completed	2
DB00977	Ethinylestradiol	2	Terminated	1
DB12010	Fostamatinib	2	Completed	1
DB00406	Gentian violet cation	2	Active Not Recruiting	1
DB00406	Gentian violet cation	2	Not Yet Recruiting	1
DB11834	Guselkumab	2	Completed	2
DB16666	Ianalumab	2	Recruiting	1
DB16658	Imsidolimab	2	Completed	1
DB00065	Infliximab	2	Completed	1
DB02325	Isopropyl alcohol	2	Completed	1
DB16224	Lutikizumab	2	Recruiting	1
DB16452	MAS825	2	Recruiting	1
DB14009	Medical Cannabis	2	Withdrawn	1
DB09241	Methylene blue	2	Active Not Recruiting	1
DB09567	Olive oil	2	Withdrawn	1
DB14762	Risankizumab	2	Completed	1
DB08877	Ruxolitinib	2	Completed	1
DB08877	Ruxolitinib	2	Recruiting	1
DB09153	Sodium chloride	2	Completed	1
DB15626	Spesolimab	2	Active Not Recruiting	1
DB15626	Spesolimab	2	Completed	1
DB08895	Tofacitinib	2	Recruiting	1
DB15091	Upadacitinib	2	Completed	1
DB05679	Ustekinumab	2	Completed	1
DB16416	Vilobelimab	2	Completed	2
DB09145	Water	2	Completed	1
DB15626	Spesolimab	2 / 3	Not Yet Recruiting	1
DB15626	Spesolimab	2 / 3	Recruiting	1
DB00051	Adalimumab	3	Completed	4
DB12917	Bimekizumab	3	Active Not Recruiting	1
DB12917	Bimekizumab	3	Completed	2
DB00331	Metformin	3	Completed	1
DB09029	Secukinumab	3	Active Not Recruiting	1
DB09029	Secukinumab	3	Completed	2
DB15091	Upadacitinib	3	Recruiting	1
DB00051	Adalimumab	4	Completed	1
DB00051	Adalimumab	4	Unknown Status	1
DB00051	Adalimumab	4	Withdrawn	1
DB00083	Botulinum toxin type A	4	Not Yet Recruiting	1
DB09153	Sodium chloride	4	Terminated	1
DB00421	Spironolactone	4	Withdrawn	1
DB00620	Triamcinolone	4	Terminated	1
DB00051	Adalimumab	Not Available	Completed	1
DB00051	Adalimumab	Not Available	Recruiting	1
DB09096	Benzoyl peroxide	Not Available	Completed	1
DB00083	Botulinum toxin type A	Not Available	Recruiting	1
DB00042	Botulinum toxin type B	Not Available	Completed	1
DB01190	Clindamycin	Not Available	Completed	1
DB00303	Ertapenem	Not Available	Withdrawn	1
DB00005	Etanercept	Not Available	Completed	1
DB06812	Povidone-iodine	Not Available	Completed	1
DB01045	Rifampicin	Not Available	Completed	1
DB09029	Secukinumab	Not Available	Available	1
DB15171	Tirzepatide	Not Available	Not Yet Recruiting	1
DB00620	Triamcinolone	Not Available	Completed	1